The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Re the Pierce agreement; it should be noted that the exclusive agreement is linked to attaining certain sales levels by agreed timescales, so if these are not met then Opti is free to negotiate other agreements for China.
I listened to a presentation from this company last night which on the face of it, would provide an ideal opportunity for Opti to sell their own product range in China.
https://media.moneyam.com/a/2021/05/4-Samarkand-Group-V2.pdf
Agree, LPLDL should be walking off the shelf
https://www.diabetes.org.uk/guide-to-diabetes/enjoy-food/eating-with-diabetes/managing-other-medical-conditions/cholesterol-and-diabetes
https://www.express.co.uk/life-style/health/1434452/nhs-patients-type-two-diabetes-undiagnosed
The excuses really have to stop now.
Rebarm,
A little similar to yourself as a long term holder who believes in the medium / long term performance. I do understand the time taken from developing an opportunity through to it producing a nice quarter on quarter high margin revenue contribution.
I do welcome elricos notes, but realises this merely fills a gap of consistent and accurate IR output from SOH. I am also cautious on elricos notes as he has a good product and market understanding but some real basic gaps in finance.
As a mean and skinny team I don't expect an all singing all dancing investor relations. Just accurate and timely updates directly without using selective investors.
Well rebarm, back from specsavers and what a difference it has made, those Opti shares I though I had been holding whilst they stagnated were actually Open Orphan shares and I've made a fortune; the joy of rose tinted spectacles eh! Look the Chinese market is notoriously difficult to break into at the best of times let alone when you are talking health and medical products that will need to be sold through recognised pharmas in China if they are to take off. I remember reading that the Chinese preferred way of doing business for new products is face-to-face which would have been problematic given the covid situation and the restriction on travel which is no doubt why it is a 3 year distribution agreement; give it time.
Probably not wise to come out with your typically disparaging comments when you have no idea about a poster's background. You really can't stand it when somebody posts something that may offend your view of the world, can you?
You're absolutely correct about the breakdown in relations between the CCP and the democratic world and, in my opinion, they should breakdown further. However, given the close relationship that your friends at Pierce supposedly have with the CCP and their business acumen then one would have thought that would have been factored into their discussions with Opti. Unless of course it is nothing more a convenient excuse for the lack of news?!
For your information, I suspect that I have been invested here for as long as you and probably have a significantly bigger investment. Despite the ongoing sp stagnation, I am a LTH and will remain so because I believe in the science and am confident that sooner or later the market will recognise the significance of what Opti is trying to achieve. However, like many other investors, I am now sick of the constant carrot dangling by SOH assisted by know-it-alls like your good self.
Perhaps time for OptiBiotix to change its name to Opti Manana!!
If being open and transparent is "punting aggressively", then so be it on the subject of Pierce. You are no different to so many investors that do not have the first idea of how business partnerships develop and evolve. Leaving this aside, perhaps you may ponder on how the Geopolitical environment between the UK government and the CCP may have impacted negotiations? While you ponder on this, perhaps ponder how geopolitical events between Australia and CCP?
I am not going to expand on developments no matter how baiting there is. You will just have to remain patient. The following article should offer some scope as to how some things take longer than we shareholders expect, but are actually part of the course, especially where new innovative science is part of the new way of doing things.
https://twitter.com/LEMMINGINVESTOR/status/1391433402830753799
So exactly what R N S were you expecting to be issued one year in to a 3 year distribution agreement on wide one?
Correct, but if your research is so superficial that it goes no further than the title of a post then it’s hardly surprising that you missed the content and context. Specsavers should be open tomorrow!!
Well actually Rebarm it depends how you read it; the heading created by Bubs read "Anyone remember the last time we had a decent RNS" which is NOT Pierce specific is it?
Actually Aquae, I think it's you that should be at the head of the queue for an appointment at Specsavers! The post from Bubs49 was sepcifically about the RNS May 5th 2020 regarding Pierce Group and lack of deal announcements subsequently. You've posted a very impressive list of deals signed since then not one of which reference Pierce.
I'm sure that given his role with Pierce that if any significant deals had been done then he would have been shouting from the rooftops but strange silence!!
Perhaps you could enlighten us all.
Bubs49; A list of deals in the last 12 months for those too blind to see
18th Nov 2020 7:00 am RNS License and supply agreement with Genuine Health
12th Oct 2020 7:00 am RNS Launch of weight management products
launch of meal replacement shakes and bars containing OptiBiotix's OptiBiome® proprietary weight management technology under the Optislim® brand with Woolworths, ChemistWarehouse and on OptiPharm Pty Ltd's ("OptiPharm") online store in Australia and New Zealand.
6th Oct 2020 7:00 am RNS Exclusive distribution agreement
exclusive distribution agreement with United Italian Trading Corporation (Pte) Ltd ("UITC") to distribute OptiBiotix's cholesterol reducing product, CholBiomeX3, in Singapore.
28th Sep 2020 7:00 am RNS Exclusive distribution agreement
OptiBiotix Health plc (AIM: OPTI), a life sciences business developing compounds to tackle obesity, high cholesterol, diabetes and skincare, announces it has entered into an exclusive distribution agreement for SlimBiome® Medical with United Italian Trading Corporation (Pte) Ltd ("UITC"). The agreement grants UITC exclusive rights to distribute OptiBiotix's SlimBiome®
Medical proprietary weight management product in Singapore.
22nd Sep 2020 7:00 am RNS License agreement for SlimBiome® Medical in the US
Non-Exclusive License Agreement with HiLife Vitamins for SlimBiome® Medical in the USA
15th Sep 2020 7:00 am RNS SweetBiotix sweet fibres agreement
1st Jul 2020 7:00 am RNS Distribution agreement with Actial Farmaceutica
OptiBiotix Health plc (AIM: OPTI), a life sciences business developing compounds to tackle obesity, high
20th May 2020 7:00 am RNS Launch of SlimBiome gummies in USA
cholesterol, diabetes and skincare, announces that the Company has entered into a non-exclusive license agreement for its SlimBiome® trademark with Evolution_18 ("Evolution_18") and related launch of fibre gummies containing OptiBiotix's SlimBiome® proprietary weight management technology.
11th May 2020 7:00 am RNS Exclusive distribution agreement with MAXCARE Inc
Bubs49.
Suggest you ask Elrico who has a vested interest in Pierce's success. He was punting aggressively when the agreement with Opti was announced last year but, unless too small to warrant an RNS, nothing appears to have happened.
Check out his blog under 'Elrico & Pierce ESIM Disclosure'. Apparently he has a 1% interest in Pierce!!
In all probability, Pierce is another Tata, albeit significantly smaller.
things have gone really quiet, but believe there are lots of things happening, just not many announcements.
Over a year ago now the collaboration with Pierce group announced. Since then not one RNS deal announced. Not one.